← Back to Search

Procedure

Hyperbaric Oxygen Therapy for Long COVID (PCS-HBOT Trial)

N/A
Waitlist Available
Led By Jordan Tarshis, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years old
Officially diagnosed with post COVID-19 condition by a healthcare practitioner
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after last hbot treatment and at 12 month follow-up
Awards & highlights

PCS-HBOT Trial Summary

This trial is exploring a new treatment for post COVID-19 symptoms, such as fatigue, using hyperbaric oxygen therapy. The findings could help decide if this treatment is feasible for a large-scale research study.

Who is the study for?
Adults diagnosed with post COVID-19 condition, experiencing chronic fatigue and at least one other symptom like 'brain fog' or anxiety for over 12 weeks since infection. Excludes those with traumatic brain injury, unstable living situations, pregnant women or those planning pregnancy, pre-existing cognitive issues, and anyone unfit for hyperbaric treatments.Check my eligibility
What is being tested?
The trial is testing hyperbaric oxygen therapy—a treatment where patients breathe high levels of oxygen in a special chamber—to see if it can alleviate symptoms of post COVID-19 condition such as persistent fatigue and 'brain fog'.See study design
What are the potential side effects?
While not specified here, common side effects of hyperbaric oxygen therapy may include ear pressure changes leading to discomfort or pain, temporary vision changes, and rarely lung collapse due to air pressure changes.

PCS-HBOT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been officially diagnosed with long COVID.

PCS-HBOT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after last hbot treatment and at 12 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and after last hbot treatment and at 12 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to HBOT protocol
Adherence to HBOT protocol - satisfaction
Feasibility of Clinical Outcome Measures
+3 more
Secondary outcome measures
Initial infection severity as a mediator of HBOT impact - FSS
Initial infection severity as a mediator of HBOT impact - PDQ
Initial infection severity as a mediator of HBOT impact - SF-36
+9 more

PCS-HBOT Trial Design

2Treatment groups
Experimental Treatment
Group I: Immediate start of hyperbaric treatmentsExperimental Treatment1 Intervention
HBOT treatments will be scheduled to start immediately after referral.
Group II: Delayed start of hyperbaric treatmentsExperimental Treatment1 Intervention
HBOT treatments will be scheduled to start 60 days after referral.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,397 Total Patients Enrolled
1 Trials studying Fatigue
26 Patients Enrolled for Fatigue
Jordan Tarshis, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
Fahad Alam, MDPrincipal InvestigatorSunnybrook Health Sciences Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently recruiting participants?

"Contrary to what was previously thought, information from clinicaltrials.gov reveals that this medical study is not recruiting at the present moment. The trial initially opened its doors on October 1st 2023 and had a final edit made on October 12th 2023. Fortunately for patients searching for trials, there are 2325 other studies actively looking for participants right now."

Answered by AI

What is the fundamental purpose of this experiment?

"Over the course of 9 months, this clinical trial will measure patient recruitment rate as its primary outcome. Subsidiary objectives include gauging hyperbaric oxygen therapy's effect on post-COVID fatigue (with Fatigue Severity Scale) and quality of life (via SF-36), with a comparison between immediate HBOT treatments versus delayed ones using PDQ scales."

Answered by AI
~27 spots leftby Dec 2025